NOT-AI-05-035: Amendment to PAR-03-138 "Novel HIV Therapies: Integrated Preclinical/Clinical Program”

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®

Amendment to PAR-03-138 "Novel HIV Therapies: Integrated Preclinical/Clinical Program

Notice Number: NOT-AI-05-035

Key Dates
Release Date: April 12, 2005
Application Receipt Date(s): November 17, 2005
Peer Review Date(s): March, 2006
Council Review Date(s) : May, 2006
Earliest Anticipated Start Date: June 2006
Expiration Date: November 18, 2005

Issued by
National Institute of Allergy and Infectious Diseases (NIAID), (http://www.niaid.nih.gov/)
National Institute of Mental Health (NIMH), (http://www.nimh.nih.gov)

The National Institute of Allergy and Infectious Diseases (NIAID) is amending PAR-03-138, Novel HIV Therapies: Integrated Preclinical/Clinical Program as follows.

The new contact for peer review issues is now:

Dr. Eugene Baizman
Division of Extramural Affairs
National Institute of Allergy and Infectious Diseases
Room Number 3125, MSC-7616
6700-B Rockledge Drive
Bethesda, MD 20892
Telephone: (301) 496-2550
FAX: (301) 402-2638
Email: [email protected]

In addition the two extra copies of the application packet and all five sets of appendix material are to be sent to Dr. Baizman.

Inquiries

Direct questions about NIAID scientific/research issues to:

Sandra Bridges, Ph.D.
Division of AIDS
National Institute of Allergy and Infectious Diseases
Room 4128, MSC-7626
6700-B Rockledge Drive
Bethesda, MD 20892-7626
Telephone: (301) 496-8198
FAX: (301) 402-3211
Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices